Results 11 to 20 of about 70,027 (183)
Advanced Biomedical Research, 2016 Background: Hydroxychloroquine can improve most underlying coronary risk factors; however, there are a few studies on the effects of hydroxychloroquine on blood glucose and insulin resistance.
Fahimeh Sheikhbahaie +4 more
doaj +2 more sources
Interaction of Hydroxychloroquine with Pharmacokinetically Important Drug Transporters
Pharmaceutics, 2020 (1) Background: Hydroxychloroquine is used to treat malaria and autoimmune diseases, and its potential use against COVID-19 is currently under investigation.
Johanna Weiss +2 more
doaj +2 more sources
Case Reports in Infectious Diseases, 2020 Hydroxychloroquine has gained popularity as a potential preventative and treatment of COVID-19 pneumonia due to its in vitro activity against the virus.
Awan K. Rahman +2 more
doaj +2 more sources
Macular edema might be a rare presentation of hydroxychloroquine-induced retinal toxicity
Taiwan Journal of Ophthalmology, 2017 The aim of this study is to report a rare case of macular edema as a presentation of hydroxychloroquine-related retinal toxicity. We presented a case of a 46-year-old female patient using hydroxychloroquine for underlying rheumatoid arthritis (RA) with ...
Chih-Yao Chang, Shwu-Jiuan Sheu
doaj +2 more sources
Renal potassium wasting from hydroxychloroquine at therapeutic doses: a case report
BMC NephrologyBackground Hydroxychloroquine is a common disease-modifying treatment for systemic autoimmune disease and is usually well-tolerated. In acute hydroxychloroquine or chloroquine toxicity, hypokalemia typically reflects a transient intracellular potassium ...
Justin David Tse, Sourabh Kharait
doaj +2 more sources
Do Chloroquine and Hydroxychloroquine Treat COVID-19? [PDF]
, 2021 Chloroquine is an anti-malarial and autoimmune disease drug, which has an anti- viral activity. In vitro, the Chloroquine and Hydroxychloroquine are potent at inhibiting SARS-CoV.
Sanaa Bouchnafati +3 more
core +1 more source
Hydroxychloroquine retinopathy [PDF]
Eye, 2017 Hydroxychloroquine (HCQ; Plaquenil) is used increasingly in the management of a variety of autoimmune disorders, with well established roles in dermatology and rheumatology and emerging roles in oncology. Hydroxychloroquine has demonstrated a survival benefit in patients with systemic lupus erythematosus; some clinicians advocate its use in all such ...
Yusuf, I +3 more
openaire +2 more sources
Hydroxychloroquine and Antimalarials [PDF]
The Journal of Rheumatology, 2019 We read the editorial by Sandhu, et al1 about antimalarial-induced cardiomyopathy in systemic lupus erythematosus2, and we want to point out some inaccuracies in the brief review of the history of antimalarials that they presented.
LUIS CAMINAL-MONTERO +1 more
openaire +2 more sources
Newly Developed Semi-Synthetic Chloroquine and Hydroxychloroquine-Phytochemical Conjugates as Prospective COVID-19 Drug(s) [PDF]
, 2020 Dear Editor, Kindly find a research article entitled “Newly developed semi-synthetic chloroquine and hydroxychloroquine-phytochemical conjugates as prospective COVID-19 drug(s)”, submitted for consideration for publication.
Chita Ranjan, Sahoo +2 more
core +1 more source
A call to caution when hydroxychloroquine is given to elderly patients with COVID-19
International Journal of Infectious Diseases, 2021 Introduction: Use of hydroxychloroquine in patients with coronavirus disease 2019 (COVID-19) was widespread and uncontrolled until recently. Patients vulnerable to severe COVID-19 are at risk of hydroxychloroquine interactions with co-morbidities and co ...
Julian J. Gabor +23 more
doaj +1 more source